Literature DB >> 32725162

Amplification of Salt-Sensitive Hypertension and Kidney Damage by Immune Mechanisms.

David L Mattson1, John Henry Dasinger1, Justine M Abais-Battad1.   

Abstract

Humans with salt-sensitive (SS) hypertension demonstrate increased morbidity, increased mortality, and renal end-organ damage when compared with normotensive subjects or those with salt-resistant hypertension. Increasing evidence indicates that immune mechanisms play an important role in the full development of SS hypertension and associated renal damage. Recent experimental advances and studies in animal models have permitted a greater understanding of the mechanisms of activation and action of immunity in this disease process. Evidence favors a role of both innate and adaptive immune mechanisms that are triggered by initial, immune-independent alterations in blood pressure, sympathetic activity, or tissue damage. Activation of immunity, which can be enhanced by a high-salt intake or by alterations in other components of the diet, leads to the release of cytokines, free radicals, or other factors that amplify renal damage and hypertension and mediate malignant disease. © American Journal of Hypertension, Ltd 2020. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; hypertension; immune cells; kidney

Year:  2021        PMID: 32725162      PMCID: PMC7891248          DOI: 10.1093/ajh/hpaa124

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  135 in total

Review 1.  Immune and inflammatory role in renal disease.

Authors:  John D Imig; Michael J Ryan
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

Review 2.  Chemokines and chemokine receptors: update on utility and challenges for the clinician.

Authors:  Ishan Roy; Douglas B Evans; Michael B Dwinell
Journal:  Surgery       Date:  2014-02-08       Impact factor: 3.982

3.  Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.

Authors:  Ruben Poesen; Ali Ramezani; Kathleen Claes; Patrick Augustijns; Dirk Kuypers; Ian R Barrows; Jagadeesan Muralidharan; Pieter Evenepoel; Björn Meijers; Dominic S Raj
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-07       Impact factor: 8.237

4.  Ribonucleic acid interference knockdown of interleukin 6 attenuates cold-induced hypertension.

Authors:  Patrick Crosswhite; Zhongjie Sun
Journal:  Hypertension       Date:  2010-04-12       Impact factor: 10.190

5.  Inflammatory cellular reaction in hypertensive vascular disease in man.

Authors:  F Olsen
Journal:  Acta Pathol Microbiol Scand A       Date:  1972

6.  Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats.

Authors:  Bernardo Rodríguez-Iturbe; Yasmir Quiroz; Mayerly Nava; Lizzette Bonet; Maribel Chávez; Jaime Herrera-Acosta; Richard J Johnson; Héctor A Pons
Journal:  Am J Physiol Renal Physiol       Date:  2002-02

Review 7.  Reactive oxygen species as important determinants of medullary flow, sodium excretion, and hypertension.

Authors:  Allen W Cowley; Michiaki Abe; Takefumi Mori; Paul M O'Connor; Yusuke Ohsaki; Nadezhda N Zheleznova
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-29

Review 8.  Infiltrating immune cells in the kidney in salt-sensitive hypertension and renal injury.

Authors:  David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-09

9.  Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

Authors:  Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

10.  Salt-responsive gut commensal modulates TH17 axis and disease.

Authors:  Nicola Wilck; Mariana G Matus; Sean M Kearney; Scott W Olesen; Kristoffer Forslund; Hendrik Bartolomaeus; Stefanie Haase; Anja Mähler; András Balogh; Lajos Markó; Olga Vvedenskaya; Friedrich H Kleiner; Dmitry Tsvetkov; Lars Klug; Paul I Costea; Shinichi Sunagawa; Lisa Maier; Natalia Rakova; Valentin Schatz; Patrick Neubert; Christian Frätzer; Alexander Krannich; Maik Gollasch; Diana A Grohme; Beatriz F Côrte-Real; Roman G Gerlach; Marijana Basic; Athanasios Typas; Chuan Wu; Jens M Titze; Jonathan Jantsch; Michael Boschmann; Ralf Dechend; Markus Kleinewietfeld; Stefan Kempa; Peer Bork; Ralf A Linker; Eric J Alm; Dominik N Müller
Journal:  Nature       Date:  2017-11-15       Impact factor: 49.962

View more
  5 in total

Review 1.  T Cell Immunometabolism and Redox Signaling in Hypertension.

Authors:  David L Mattson; Justine M Abais-Battad
Journal:  Curr Hypertens Rep       Date:  2021-12-09       Impact factor: 5.369

2.  Effects of elevation of ANP and its deficiency on cardiorenal function.

Authors:  Daria V Ilatovskaya; Vladislav Levchenko; Kristen Winsor; Gregory R Blass; Denisha R Spires; Elizaveta Sarsenova; Iuliia Polina; Adrian Zietara; Mark Paterson; Alison J Kriegel; Alexander Staruschenko
Journal:  JCI Insight       Date:  2022-05-09

Review 3.  Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed.

Authors:  Silvio Borrelli; Luca De Nicola; Ilaria De Gregorio; Lucio Polese; Luigi Pennino; Claudia Elefante; Alessandro Carbone; Tiziana Rappa; Roberto Minutolo; Carlo Garofalo
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

4.  Upregulation of Mineralocorticoid Receptor Contributes to Development of Salt-Sensitive Hypertension after Ischemia-Reperfusion Injury in Rats.

Authors:  Takumi Matsumoto; Shigehiro Doi; Ayumu Nakashima; Takeshi Ike; Kensuke Sasaki; Takao Masaki
Journal:  Int J Mol Sci       Date:  2022-07-15       Impact factor: 6.208

Review 5.  Contribution of Th17 cells to tissue injury in hypertension.

Authors:  David P Basile; Justine M Abais-Battad; David L Mattson
Journal:  Curr Opin Nephrol Hypertens       Date:  2021-03-01       Impact factor: 2.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.